医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

DSG, Inc. Accelerates Growth with Opening of New Office in Bangalore, India

2017年01月20日 PM10:00
このエントリーをはてなブックマークに追加


 

MALVERN, Pa. & BANGALORE, India

DSG, Inc., leading provider of eClinical technology solutions, data management, professional services and customer support recently opened a new office in Bangalore, India, to accommodate rapid growth and better serve client needs. DSG’s Bangalore office will complement its existing facility located in Noida, India. DSG Bangalore’s state-of-the-art facility will occupy a floor in the Prestige Shantiniketan building. The new office space will accommodate over 300 people and support the company’s growth strategy. In expanding its footprint, DSG adds expertise, scale, and breadth of services, adding staff from a highly skilled pool of manager-level employees bringing years of industry experience from some of the largest pharmaceutical companies and global Clinical Research Organizations.

“Since creating our India division in 2008, DSG has run a highly efficient and successful operation there leveraging identical SOPs established in our U.S. operations,” said DSG’s CEO, Tony Varano. “We realize some U.S.-based CROs and service organizations have tried and failed to find the winning formula, but we have, and continue to make excellent use of India’s incredible talent pool. This latest expansion into Bangalore is proof positive, and our clients reap the benefits of DSG’s 20-hour work day and unmatched eClinical systems delivery and support track record.”

About DSG

DSG, Inc. supports clinical data capture and management with a proprietary, organically integrated suite of award-winning user-friendly technology solutions, including flagship eCaseLink™ EDC, Risk-Based Monitoring, eSource, ePRO, IWRS Randomization-Clinical Supply Systems, Drug Safety System, and CTMS. Since 1992, DSG has successfully supported thousands of clinical trials for over 400 companies and 25,000 sites across 93 countries, headquartered in Malvern, Pa., with additional offices in the U.S. and Asia: www.dsg-us.com.

All products and services above are the property of their respective owners.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170120005008/en/

CONTACT

DSG, Inc.
Jack Minster, +1 484-913-2112
jminster@dsg-us.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Apros Therapeutics Announces IND Clearance from U.S. FDA to Initiate the Trial of APR003, an Orally-Administered Gastrointestinal/Liver-Targeted TLR7 Agonist for Treatment of Advanced Colorectal Cancer (CRC) with Malignant Liver Lesions
  • Taiwan Innotech Expo (TIE) Showcases Strong Ecosystems in the Post-Pandemic World
  • Dr. Reddy’s Laboratories announces the launch of Over-The-Counter Diclofenac Sodium Topical Gel 1%, the store brand version of Voltaren® Arthritis Pain in the U.S. Market
  • GC Pharma Taps Small Molecule AI Expert Atomwise to Expand Hemophilia Franchise
  • 随着越来越多的客户和合作伙伴使用Denodo冠状病毒数据门户计划来对抗和最小化COVID-19的影响,其采纳率在不断提高